HBM1022, A NOVEL ANTI-CCR8 ANTIBODY DEPLETES TUMOR-INFILTRATING REGULATORY T CELLS VIA ENHANCED ADCC ACTIVITY, MEDIATES POTENT ANTI-TUMOR ACTIVITY WITH KEYTRUDA

Lu, S; Hu, SP; Gan, X; Wang, YQ; Zhao, CC; Ding, Y; He, JQ; Du, Q; Lv, XC; Qin, BB; He, Y; Niu, L; Wu, YT; Chen, F; Wang, YD; Yang, YX; Cao, Y; Bao, MS; Noon, J; Yu, WH; Liu, J; Zhao, J; Rong, YP; Lu, S

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020; 8 (): A426

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索